Mile High Labs Acquires State-Of-The-Art Pharmaceutical Facility in Broomfield, Colorado

  • Leading producer of CBD plans to create global center for CBD
  • 400,000-square-foot facility provides maximum capacity for growing demand
  • Acquisition will be a boon for Broomfield

BOULDER, Colo., June 20, 2019 (GLOBE NEWSWIRE) — Mile High Labs, the largest manufacturer of CBD isolate in the world, today announced the purchase of a 400,000 square foot pharmaceutical production facility in Broomfield, Colorado. The transaction was closed on June 19 and includes the land, labs, building, and ready-to-use finished products manufacturing equipment.

Many analysts have been openly wondering when pharma would take over the CBD industry, but what if the opposite were true?

Stephen Mueller, chief technology officer and founder, Mile High Labs

This transaction is the largest infrastructure purchase in the history of the CBD market and it’s only the beginning for Mile High Labs. Over the coming quarters, we plan to leverage this tremendous infrastructure to build the global center for CBD products manufacturing.

The Broomfield facility is fully operational, which allows Mile High Labs to begin production in the near term of private label products including tinctures, capsules, tablets, topicals, and gummies. The facility includes equipment and infrastructure for research and development, quality assurance, bottling, filling, packing, warehousing, labeling, shipping and compliance monitoring.


Colorado is the center of the hemp industry and, within it, the Mile High Labs campus will be its epicenter. The company plans to create an environment for advanced training, research and collaboration within the industry.

“CBD is an amazing molecule that we’re only beginning to understand,” said Mr. Mueller. “Just as Silicon Valley in California has fostered innovation and collaboration in the tech industry, Mile High Labs will create a CBD Center for our industry to learn, innovate, grow and succeed.”


The Broomfield campus marks the third move since the Colorado company was founded in 2016. Originally based in Longmont, production moved to a larger building in Loveland in 2017. The company began looking for a larger facility after the passage of the 2018 Farm Bill legalized hemp and created unprecedented demand for CBD.

“In light of recent legislative developments, the demand for our products has increased considerably,” said Mr. Mueller. “And it’s not just a domestic phenomenon. CBD is a global product and we serve a global customer base. This large-scale production facility will ensure we have the capacity to provide high quality, consistent CBD to every customer, large or small.”


Mile High Labs employs people in mid- and high-wage fields ranging from production, engineering, maintenance, and fulfillment to sales, accounting, marketing, research and development, and regulation/compliance.

“We are grateful to the City of Broomfield and the State of Colorado for creating an environment where we can be a long-term partner in the economic success of this community,” said Mr. Mueller. “We look forward to continued growth and hope Broomfield residents and current and former employees of the facility will consider new opportunities with us.”


Mile High Labs is a large-scale CBD ingredient and product manufacturer offering reliable delivery of bulk CBD and private label services to the world’s leading consumer brands. With a GMP-certified facility and extensive network of contracted cultivators, Mile High Labs supplies high-quality, high-volume CBD orders year-round. Mile High Labs extracts exclusively from industrial hemp material. More at

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter